Atlas Trials

Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.

Clinical trial NCT05725876 · RECRUITING

Trial details

NCT number
NCT05725876
Sponsor
University Medical Center Groningen
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
PsoriasisCrohn Disease
Start date
2025-01-06
Primary completion
2026-07-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.